Edwards Lifesciences Corporation ( EW ) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR November 2, 2026 8:00 PM EST
Company Participants
Bernard Zovighian - CEO & Director
Daniel Lippis - Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)
Conference Call Participants
Charles J Davidson
Michael Polark - Wolfe Research, LLC
Pito Chickering - Deutsche Bank AG, Research Division
Patrick Wood
David Rescott - Robert W. Baird & Co. Incorporated, Research Division
Philippe Genereux
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
Martin Leon
Robert Marcus - JPMorgan Chase & Co, Research Division
Travis Steed - BofA Securities, Research Division
Matthew Taylor - Jefferies LLC, Research Division
Joanne Wuensch - Citigroup Inc., Research Division
Conversation
Unknown Executive
All right. Glad everyone could join us today. Thanks so much for coming.…